Publications for Dennis Yue
Publications for Dennis Yue
2016
Al-Saeed, A., Constantino, M., Molyneaux, L.,
D'Souza, M., Limacher-Gisler, F., Luo, C., Wu,
T., Twigg, S., Yue, D., Wong, J. (2016). An
Inverse Relationship Between Age of Type 2
Diabetes Onset and Complication Risk and
Mortality: The Impact of Youth-Onset Type 2
Diabetes. Diabetes Care, 39(5), 823-829. <a
href="http://dx.doi.org/10.2337/dc15-0991">[M
ore Information]</a>
Lee, A., Brooks, B., Simmons, L., Kilborn, M.,
Wong, J., Twigg, S., Yue, D. (2016).
Hypoglycaemia and QT interval prolongation:
Detection by simultaneous Holter and continuous
glucose monitoring. Diabetes Research and
Clinical Practice, 113, 211-214. <a
href="http://dx.doi.org/10.1016/j.diabres.2016.01
.005">[More Information]</a>
Carleton, V., Hinchcliffe, M., Pinner, J., Cole, S.,
Mercorella, B., Molyneaux, L., Constantino, M.,
Yue, D., Ross, G., Wong, J. (2016). Identifying
Glucokinase Monogenic Diabetes in a
Multiethnic Gestational Diabetes Cohort: New
Pregnancy Screening Criteria and Utility of
HbA1c. Diabetes Care, 39(1), 50-52. <a
href="http://dx.doi.org/10.2337/dc15-1001">[M
ore Information]</a>
2015
Alharbi, T., Constantino, M., Molyneaux, L.,
Wu, T., Twigg, S., Yue, D., Wong, J. (2015).
Ethnic specific differences in survival of patients
with type 2 diabetes: Analysis of data collected
from an Australian multi-ethnic cohort over a 25
year period. Diabetes Research and Clinical
Practice, 107(1), 130-138. <a
href="http://dx.doi.org/10.1016/j.diabres.2014.09
.037">[More Information]</a>
Wong, J., Constantino, M., Yue, D. (2015).
Morbidity and mortality in young-onset type 2
diabetes in comparison to type 1 diabetes: where
are we now? Current Diabetes Reports, 15(1),
566. <a
href="http://dx.doi.org/10.1007/s11892-014-056
6-1">[More Information]</a>
Rudland, V., Pech, C., Harding, A., Tan, K., Lee,
K., Molyneaux, L., Yue, D., Wong, J., Ross, G.
(2015). Zinc transporter 8 autoantibodies: what is
their clinical relevance in gestational diabetes?
Diabetic Medicine, 32(3), 359-366. <a
href="http://dx.doi.org/10.1111/dme.12629">[M
ore Information]</a>
2014
Hsieh, A., Ong, P., Molyneaux, L., McGill, M.,
Constantino, M., Wu, T., Wong, J., Yue, D.,
Twigg, S. (2014). Age of diabetes diagnosis and
diabetes duration associate with glycated
haemoglobin. Diabetes Research and Clinical
Practice, 104(1), e1-e4. <a
href="http://dx.doi.org/10.1016/j.diabres.2014.02
.004">[More Information]</a>
Zhang, X., Brooks, B., Molyneaux, L., Landy,
E., Banatwalla, R., Wu, T., Wong, J., Su, B.,
Yue, D. (2014). Dipeptidyl Peptidase-4
Inhibitors as a Third-Line Oral
Antihyperglycaemic Agent in Patients with Type
2 Diabetes Mellitus: The Impact of Ethnicity.
International Journal of Endocrinology, 2014,
1-5. <a
href="http://dx.doi.org/10.1155/2014/354040">[
More Information]</a>
Yale, J., Bakris, G., Cariou, B., Nieto, J.,
David-Neto, E., Yue, D., Wajs, E., Figueroa, K.,
Jiang, J., Law, G., et al (2014). Efficacy and
safety of canagliflozin over 52 weeks in patients
with type 2 diabetes mellitus and chronic kidney
disease. Diabetes, Obesity and Metabolism,
16(10), 1016-1027. <a
href="http://dx.doi.org/10.1111/dom.12348">[M
ore Information]</a>
2013
Yale, J., Bakris, G., Cariou, B., Yue, D., David
Neto, E., Xi, L., Figueroa, K., Wajs, E., Usiskin,
K., Meininger, G. (2013). Efficacy and safety of
canagliflozin in subjects with type 2 diabetes and
chronic kidney disease. Diabetes, Obesity and
Metabolism, 15(5), 463-473. <a
href="http://dx.doi.org/10.1111/dom.12090">[M
ore Information]</a>
Leader, N., Ryan, L., Molyneaux, L., Yue, D.
(2013). How best to use partial meal replacement
in managing overweight or obese patients with
poorly controlled type 2 diabetes. Obesity, 21(2),
251-253. <a
href="http://dx.doi.org/10.1002/oby.20057">[Mo
re Information]</a>
Liu, Y., Brooks, B., McCosker, S., Molyneaux,
L., Yue, D. (2013). How do we distinguish loss
of vibration sensation due to neuropathy from
that due to ageing? Practical Diabetes, 30(5),
186-188. <a
href="http://dx.doi.org/10.1002/pdi.1773">[Mor
e Information]</a>
Constantino, M., Molyneaux, L.,
Limacher-Gisler, F., Al-Saaed, A., Luo, C., Wu,
T., Twigg, S., Yue, D., Wong, J. (2013).
Long-Term Complications and Mortality in
Young-Onset Diabetes: Type 2 diabetes is more
hazardous and lethal than type 1 diabetes.
Diabetes Care, 36(12), 3863-3869. <a
href="http://dx.doi.org/10.2337/dc12-2455">[M
ore Information]</a>
2012
Publications for Dennis Yue
Min, D., Brooks, B., Wong, J., Salomon, R.,
Bao, W., Harrisberg, B., Twigg, S., Yue, D.,
McLennan, S. (2012). Alterations in Monocyte
CD16 in Association with Diabetes
Complications. Mediators of Inflammation,
2012, 1-10. <a
href="http://dx.doi.org/10.1155/2012/649083">[
More Information]</a>
Chakera, A., Carleton, V., Ellard, S., Wong, J.,
Yue, D., Pinner, J., Hattersley, A., Ross, G.
(2012). Antenatal diagnosis of fetal genotype
determines if maternal hyperglycemia due to a
glucokinase mutation requires treatment.
Diabetes Care, 35(9), 1832-1834. <a
href="http://dx.doi.org/10.2337/dc12-0151">[M
ore Information]</a>
Simmons, L., Molyneaux, L., Yue, D., Chua, E.
(2012). Steroid-Induced Diabetes: Is It Just
Unmasking of Type 2 Diabetes? ISRN
Endocrinology, 2012, 1-5. <a
href="http://dx.doi.org/10.5402/2012/910905">[
More Information]</a>
2011
Pertot, T., Molyneaux, L., Tan, K., Ross, G.,
Yue, D., Wong, J. (2011). Can Common Clinical
Parameters be used to Identify Patients Who Will
Need Insulin Treatment in Gestational Diabetes
Mellitus? Diabetes Care, 34(10), 2214-2216. <a
href="http://dx.doi.org/10.2337/dc11-0499">[M
ore Information]</a>
Lo, L., McLennan, S., Williams, P., Bonner, J.,
Chowdhury, S., McCaughan, G., Gorrell, M.,
Yue, D., Twigg, S. (2011). Diabetes is a
progression factor for hepatic fibrosis in a high
fat fed mouse obesity model of non-alcoholic
steatohepatitis. Journal of Hepatology, 55(2),
435-444. <a
href="http://dx.doi.org/10.1016/j.jhep.2010.10.0
39">[More Information]</a>
Perera, N., Molyneaux, L., Constantino, M.,
McGill, M., Yue, D., Twigg, S., Ross, G. (2011).
Suboptimal Performance of Blood Glucose
Meters in an Antenatal Diabetes Clinic. Diabetes
Care, 34(2), 335-337. <a
href="http://dx.doi.org/10.2337/dc10-1457">[M
ore Information]</a>
Perera, N., Stewart, P., Williams, P., Chua, E.,
Yue, D., Twigg, S. (2011). The danger of using
inappropriate point-of-care glucose meters in
patients on icodextrin dialysis. Diabetic
Medicine, 28(10), 1272-1276. <a
href="http://dx.doi.org/10.1111/j.1464-5491.201
1.03362.x">[More Information]</a>
Perera, N., Harding, A., Constantino, M.,
Molyneaux, L., McGill, M., Chua, E., Twigg, S.,
Ross, G., Yue, D. (2011). Triple-B
(basal-bolus-booster) subcutaneous insulin
regimen: A pragmatic approach to managing
hospital inpatient hyperglycaemia. Practical
Diabetes, 28(6), 266-269. <a
href="http://dx.doi.org/10.1002/pdi.1612">[Mor
e Information]</a>
2010
Thomson, S., McLennan, S., Hennessy, A.,
Boughton, P., Bonner, J., Zoellner, H., Yue, D.,
Twigg, S. (2010). A novel primate model of
delayed wound healing in diabetes: dysregulation
of connective tissue growth factor. Diabetologia,
53, 572-583. <a
href="http://dx.doi.org/10.1007/s00125-009-161
0-6">[More Information]</a>
Wong, J., Molyneaux, L., Constantino, M.,
Twigg, S., Yue, D. (2010). Beyond
ONTARGET: Angiotensin-Converting Enzyme
Inhibition and Angiotensin II Receptor Blockade
in Combination, a Lesser Evil in Some?
Diabetes, Obesity and Metabolism, 12(12),
1072-1078. <a
href="http://dx.doi.org/10.1111/j.1463-1326.201
0.01298.x">[More Information]</a>
Bao, W., Min, D., Twigg, S., Shackel, N.,
Warner, F., Yue, D., McLennan, S. (2010).
Monocyte CD147 is induced by advanced
glycation end products and high glucose
concentration: possible role in diabetic
complications. American Journal of Physiology:
Cell Physiology, 299(5), C1212-C1219. <a
href="http://dx.doi.org/10.1152/ajpcell.00228.20
10">[More Information]</a>
Ban, C., Twigg, S., Franjic, B., Brooks, B.,
Celermajer, D., Yue, D., McLennan, S. (2010).
Serum MMP-7 is increased in diabetic renal
disease and diabetic diastolic dysfunction.
Diabetes Research and Clinical Practice, 87(3),
335-341. <a
href="http://dx.doi.org/10.1016/j.diabres.2010.01
.004">[More Information]</a>
Overland, J., McGill, M., Yue, D. (2010). The
Role of Community and Specialist Services. In
Richard I.G. Holt, Clive S. Cockram, Allan
Flyvbjerg, Barry J. Goldstein (Eds.),
International Textbook of Diabetes Mellitus:4th
Edition. United Kingdom: Wiley-Blackwell
Publishing.
2009
Luo, C., Wong, J., Brown, M., Hooper, M.,
Molyneaux, L., Yue, D. (2009). Hypovitaminosis
D in Chinese type 2 diabetes: lack of impact on
clinical metabolic status and biomarkers of
cellular inflammation. Diabetes and Vascular
Disease Research, 6(3), 194-199. <a
href="http://dx.doi.org/10.1177/1479164109337
974">[More Information]</a>
Liu, Y., Min, D., Bolton, T., Nube, V., Twigg,
Publications for Dennis Yue
S., Yue, D., McLennan, S. (2009). Increased
Matrix Metalloproteinase-9 Predicts Poor Wound
Healing in Diabetic Foot Ulcers. Diabetes Care,
32(1), 117-119. <a
href="http://dx.doi.org/10.2337/dc08-0763">[M
ore Information]</a>
href="http://dx.doi.org/10.3132/dvdr.2008.006">
[More Information]</a>
Yue, D., McGill, M. (2009). Insulin Therapy. In
Alan J. Sinclair (Eds.), Diabetes in Old Age, (pp.
265-272). United Kingdom: John Wiley & Sons.
Sorensen, L., Siddall, P., Trenell, M., Yue, D.
(2008). Differences in Metabolites in
Pain-Processing Brain Regions in Patients With
Diabetes and Painful Neuropathy. Diabetes
Care, 31(5), 980-981. <a
href="http://dx.doi.org/10.2337/dc07-2088">[M
ore Information]</a>
Overland, J., Molyneaux, L., Tewari, S.,
Fatouros, P., Melville, P., Foote, D., Wu, T.,
Yue, D. (2009). Lipohypertrophy: does it matter
in daily life? A study using a continuous glucose
monitoring system. Diabetes, Obesity and
Metabolism, 11(5), 460-463. <a
href="http://dx.doi.org/10.1111/j.1463-1326.200
8.00972.x">[More Information]</a>
Wong, J., Molyneaux, L., Zhao, D., Constantino,
M., Gray, R., Twigg, S., Xu, Z., Yue, D. (2008).
Different accelerators to early-onset Type 2
diabetes: a comparison of Anglo-Celtic and
Chinese patients. Journal of Diabetes and Its
Complications, 22(6), 389-394. <a
href="http://dx.doi.org/10.1016/j.jdiacomp.2007.
04.003">[More Information]</a>
Min, D., Lyons, G., Bonner, J., Twigg, S., Yue,
D., McLennan, S. (2009). Mesangial cell-derived
factors alter monocyte activation and function
through inflammatory pathways: possible
pathogenic role in diabetic nephropathy.
American Journal of Physiology: Renal
Physiology, 297(5), F1229-F1237. <a
href="http://dx.doi.org/10.1152/ajprenal.00074.2
009">[More Information]</a>
Brooks, B., Delaney-Robinson, C., Molyneaux,
L., Yue, D. (2008). Endothelial and neural
regulation of skin microvascular blood flow in
patients with diabetic peripheral neuropathy:
effect of treatment with the
Wong, J., McLennan, S., Molyneaux, L., Min,
D., Twigg, S., Yue, D. (2009). Mitochondrial
DNA content in peripheral blood monocytes:
relationship with age of diabetes onsetand
diabetic complications. Diabetologia, 52,
1953-1961. <a
href="http://dx.doi.org/10.1007/s00125-009-142
4-6">[More Information]</a>
2008
Cheung, N., Yue, D., Kotowicz, M., Jones, P.,
Flack, J. (2008). A comparison of diabetes
clinics with different emphasis on routine care,
complications assessment and shared care.
Diabetic Medicine, 25(8), 974-978. <a
href="http://dx.doi.org/10.1111/j.1464-5491.200
8.02522.x">[More Information]</a>
Wong, J., Nock, N., Xu, Z., Kyle, C., Daniels,
A., White, M., Yue, D., Elston, R., Mountjoy, K.
(2008). A polymorphism (D20S32e) close to the
human melanocortin receptor 3 is associated with
insulin resistance but not the metabolic
syndrome. Diabetes Research and Clinical
Practice, 80(2), 203-207. <a
href="http://dx.doi.org/10.1016/j.diabres.2007.11
.002">[More Information]</a>
Brooks, B., McLennan, S., Twigg, S., Yue, D.
(2008). Detection and characterisation of
microcirculatory abnormalities in the skin of
diabetic patients with microvascular
complications. Diabetes and Vascular Disease
Research, 5(1), 30-35. <a
isoform-specific protein kinase C β inhibitor,
ruboxistaurin. Journal of Diabetes and Its
Complications, 22(2), 88-95. <a
href="http://dx.doi.org/10.1016/j.jdiacomp.2007.
07.002">[More Information]</a>
Thomson, S., McLennan, S., Kirwan, P.,
Heffernan, S., Hennessy, A., Yue, D., Twigg, S.
(2008). Renal connective tissue growth factor
correlates with glomerular basement membrane
thickness and prospective albuminuria in a
non-human primate model of diabetes: possible
predictive marker for incipient diabetic
nephropathy. Journal of Diabetes and Its
Complications, 22(4), 284-294. <a
href="http://dx.doi.org/10.1016/j.jdiacomp.2007.
07.001">[More Information]</a>
McLennan, S., Bonner, J., Milne, S., Lo, L.,
Charlton, A., Kurup, S., Jia, J., Yue, D., Twigg,
S. (2008). The anti-inflammatory agent Propolis
improves wound healing in a rodent model of
experimental diabetes. Wound Repair and
Regeneration, 16, 706-713. <a
href="http://dx.doi.org/10.1111/j.1524-475X.200
8.00421.x">[More Information]</a>
Brooks, B., Heffernan, S., Thomson, S.,
McLennan, S., Twigg, S., Yue, D. (2008). The
Effects of Diabetes and Aminoguanidine
Treatment on Endothelial Function in a Primate
Model of Type 1 Diabetes. American Journal of
Primatology, 70(8), 796-802. <a
href="http://dx.doi.org/10.1002/ajp.20550">[Mo
re Information]</a>
Jiang, L., Wang, A., Molyneaux, L., Constantino,
M., Yue, D. (2008). The long-term impact of
ferritin level on treatment and complications of
Publications for Dennis Yue
type 2 diabetes. Diabetes, Obesity and
Metabolism, 10(6), 519-522. <a
href="http://dx.doi.org/10.1111/j.1463-1326.200
8.00855.x">[More Information]</a>
McGill, M., Molyneaux, L., Twigg, S., Yue, D.
(2008). The metabolic syndrome in type 1
diabetes: does it exist and does it matter? Journal
of Diabetes and Its Complications, 22(1), 18-23.
<a
href="http://dx.doi.org/10.1016/j.jdiacomp.2006.
10.005">[More Information]</a>
Wong, J., Twigg, S., Molyneaux, L., Yue, D.,
Constantino, M. (2008). Timing is Everything:
Age of Onset Influences Long-Term Retinopathy
Risk in Type 2 Diabetes, Independent of
Traditional Risk Factors. Diabetes Care, 31(10),
1985-1990. <a
href="http://dx.doi.org/10.2337/dc08-0580">[M
ore Information]</a>
2007
McLennan, S., Kelly, D., Schache, M., Waltham,
M., Dy, V., Langham, R., Yue, D., Gilbert, R.
(2007). Advanced glycation end products
decrease mesangial cell MMP-7: A role in matrix
accumulation in diabetic nephropathy? Kidney
International, 72(4), 481-488. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17554258">[More Information]</a>
Xu, L., McLennan, S., Lo, L., Natfaji, A.,
Bolton, T., Liu, Y., Twigg, S., Yue, D. (2007).
Bacterial load predicts healing rate in
neuropathic diabetic foot ulcers. Diabetes Care,
30(2), 378-380. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17259515">[More Information]</a>
Brooks, B., Franjic, B., Ban, C., Swaraj, K., Yue,
D., Celermajer, D., Twigg, S. (2007). Diastolic
dysfunction and abnormalities of the
microcirculation in type 2 diabetes. Diabetes,
Obesity and Metabolism, online publication(doi:
10.1111/j.1463-1326.2007.00803.x), 1-8. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17941867">[More Information]</a>
Thomson, S., McLennan, S., Hennessy, A.,
Bonner, J., Zoellner, H., Yue, D., Twigg, S.
(2007). Dysregulated inflammation predicts
reduced connective tissue growth factor
expression in a baboon wound healing model of
type 1 diabetes. The 43rd Annual Meeting of the
European Association for the Study of Diabetes
(EASD), Germany: Springer-Verlag.
McLennan, S., McGill, M., Twigg, S., Yue, D.
(2007). Improving wound-healing outcomes in
diabetic foot ulcers. Expert Review of
Endocrinology & Metabolism, 2, 205-213.
McElduff, A., Yue, D. (2007). Inhaled insulin:
where are we and where might we go? Medical
Journal of Australia, 186, 390-391. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17437391">[More Information]</a>
Nube, V., Bolton, T., Chua, E., Yue, D. (2007).
Osteomyelitis in the Diabetic Foot: What Lies
Beneath. Primary Intention, 15(2), 49-57.
2006
Nube, V., Molyneaux, L., Yue, D. (2006).
Biomechanical risk factors associated with
neuropathic ulceration of the hallux in people
with diabetes mellitus. Journal of the American
Podiatric Medical Association, 96(3), 189-197.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16707629">[More Information]</a>
Ong, C., Molyneaux, L., Constantino, M.,
Twigg, S., Yue, D. (2006). Long-term efficacy of
metformin therapy in nonobese individuals with
type 2 diabetes. Diabetes Care, 29(11),
2361-2364. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17065668">[More Information]</a>
McLennan, S., Jia, J., Milne, S., Lo, L., Bonner,
J., Yue, D., Twigg, S. (2006). Propolis, the
anti-inflammatory bee hive protectant improves
wound healing in experimental diabetes. 42nd
Annual Meeting of the European Association for
the Study of Diabetes (EASD), Germany:
Springer-Verlag.
Sorensen, L., Molyneaux, L., Yue, D. (2006).
The level of small nerve fiber dysfunction does
not predict pain in diabetic Neuropathy: a study
using quantitative sensory testing. Clinical
Journal of Pain, 22(3), 261-265. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16514326">[More Information]</a>
Molyneaux, L., Twigg, S., Yue, D., Constantino,
M., Wong, J. (2006). The metabolic syndrome in
type 2 diabetes: When does it matter? Diabetes,
Obesity and Metabolism, 8(6), 690-697. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=17026494">[More Information]</a>
Sorensen, L., Molyneaux, L., Yue, D. (2006).
The relationship among pain, sensory loss, and
small nerve fibers in diabetes. Diabetes Care,
29(4), 883-887. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16567832">[More Information]</a>
Publications for Dennis Yue
2005
Fulcher, G., Gilbert, R., Yue, D. (2005). Glargine
is superior to neutral protamine Hagedorn for
improving glycated haemoglobin and fasting
blood glucose levels during intensive insulin
therapy. Internal Medicine Journal, 35(9),
536-542. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16105155">[More Information]</a>
Li, J., Yang, G., Yue, D. (2005). Investing in
China: A network perspective on the diffusion of
FDI entry decision across countries. Academy of
Management Annual Meeting 2005, Glassboro,
NJ, USA: Academy of Management.
Skilton, M., Lai, N., Griffiths, K., Molyneaux,
L., Yue, D., Sullivan, D., Celermajer, D. (2005).
Meal-related increases in vascular reactivity are
impaired in older and diabetic adults: insights
into roles of aging and insulin in vascular flow.
American Journal of Physiology: Heart and
Circulatory Physiology, 288(3), H1404-H1410.
<a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15513964">[More Information]</a>
McGill, M., Molyneaux, L., Yue, D. (2005).
Which diabetic patients should receive podiatry
care? An objective analysis. Internal Medicine
Journal, 35(8), 451-456. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=16176466">[More Information]</a>
Nephrology, Dialysis, Transplantation, 19(7),
1792-1797.
2003
Heather, A., Fisher, E., McGrath, K., Yue, D.
(2003). High glucose alters matrix
metalloproteinase expression in two key vascular
cells: potential impact on atherosclerosis in
diabetes. Atherosclerosis, 168(2), 263-269.
2002
McLennan, S., Kelly, D., Cox, A., Cao, Z.,
Lyons, G., Yue, D., Gilbert, R. (2002).
Decreased matrix degradation in diabetic
nephropathy: effects of ACE inhibition on the
expression and activities of matrix
metalloproteinases. Diabetologia, 45, 268-275.
<a
href="http://dx.doi.org/10.1007/s00125-001-073
0-4">[More Information]</a>
McLennan, S., Martell, S., Yue, D. (2002).
Effects of mesangnium glycation on matrix
metalloproteinase activities: possible role in
diabetic nephropathy. Diabetes, 51(8),
2612-2618.
Nube, V., Yue, D., McGill, M., Molyneaux, L.
(2002). From acute to chronic: monitoring the
progress of Charcot's arthropathy. Journal of the
American Podiatric Medical Association, 92(7),
384-389.
2004
Sorensen, L., Yue, D., Molyneaux, L. (2002).
Insensate versus painful diabetic neuropathy: the
effects of height, gender, ethnicity and glycaemic
control. Diabetes Research and Clinical
Practice, 57(1), 45-51.
Thomas, M., MacIsaac, R., Tsalamandris, C.,
Molyneaux, L., Goubina, I., Fulcher, G., Yue,
D., Jerums, G. (2004). Anemia In Patients With
Type 1 Diabetes. Journal of Clinical
Endocrinology and Metabolism, 89(9),
4359-4363.
Heather, A., Nakhla, S., McGrath, K., Martell,
S., Yue, D., Celermajer, D., Jessup, W. (2002).
Nitroglycerin upregulates matrix
metalloproteinase expression by human
macrophages. Journal of the American College
of Cardiology, 39(12), 1943-1950.
McLennan, S., Wang, X., Moreno, V., Yue, D.,
Twigg, S. (2004). Connective Tissue Growth
Factor Mediates High Glucose Effects On Matrix
Degradation Through Tissue Inhibitor Of Matrix
Metalloproteinase Type 1: Implications For
Diabetic Nephropathy. Endocrinology, 145(12),
5646-5655.
Liu, D., Molyneaux, L., Chua, E., Wang, Y., Wu,
C., Jing, H., Hu, L., Liu,, Y., Xu, Z., Yue, D.
(2002). Retinopathy in a Chinese population with
type 2 diabetes: factors affecting the presence of
this complication at diagnosis of diabetes.
Diabetes Research and Clinical Practice, 56(2),
125-131.
Molyneaux, L., Constantino, M., Yue, D. (2004).
Strong Family History Predicts A Younger Age
Of Onset For Subjects Diagnosed With Type 2
Diabetes. Diabetes, Obesity and Metabolism,
6(3), 187-194.
Overland, J., Hayes, L., Yue, D. (2002). Social
disadvantage: Its impact on the use of Medicare
services related to diabetes in NSW. Australian
and New Zealand Journal of Public Health,
26(3), 262-265.
Thomas, M., MacIsaac, R., Tsalamandris, C.,
Molyneaux, L., Goubina, I., Fulcher, G., Yue,
D., Jerums, G. (2004). The Burden Of Anaemia
In Type 2 Diabetes And The Role Of
Nephropathy: A Cross-Sectional Audit.
Birrell, A., Heffernan, S., Kirwan, P., McLennan,
S., Gillin, A., Yue, D. (2002). The effects of
aminoguanidine on renal changes in a baboon
model of type 1 diabetes. Journal of Diabetes
and Its Complications, 16(4), 301-309.
Publications for Dennis Yue
2001
Premawardhana, U., Adams, M., Yue, D.,
Celermajer, D., Birrell, A. (2001).
Cardiovascular structure and function in baboons
with Type 1 diabetes - a transvenous ultrasound
study. Journal of Diabetes and Its
Complications, 15, 174-180.
Overland, J., Yue, D., Mira, M. (2001).
Continuity of care in diabetes: to whom does it
matter? Diabetes Research and Clinical
Practice, 52, 55-61.
Overland, J., Mira, M., Yue, D. (2001).
Diffential shared care for diabetes: does it
provide the optimal partition between primary
and specialist care? Diabetic Medicine, 18,
554-557.
Brooks, B., Yue, D., Dean, R., Patel, S., Wu, B.,
Molyneaux, L. (2001). TBI or not TBI: that is the
question. Is it better to measure toe pressure
than ankle pressure in diabetic patients? Diabetic
Medicine, 18, 528-532.
Overland, J., Yue, D., Mira, M. (2001). The use
of Medicare services related to diabetes: The
impact of rural isolation. ADS & ADEA Annual
Scientific Meeting, : Ads & Adea.
Overland, J., Yue, D., Mira, M. (2001). Use of
Medicare services related to diabetes care: the
impact of rural isolation. Australian Journal of
Rural Health, 9, 311-316.
2000
Birrell, A., Heffernan, S., Ansselin, A.,
McLennan, S., Church, D., Gillin, A., Yue, D.
(2000). Functional and structural abnormalities
in the nerves of Type 1 diabetic baboons:
aminoguanidine treatment does not improve
nerve function. Diabetologia, 43, 110-116.
Overland, J., Yue, D., Mira, M. (2000). The
pattern of diabetes care in New South Wales: a
five-year analysis using Medicare occasions of
service data. Australian and New Zealand
Journal of Public Health, 24, 391-395.